[HTML][HTML] The mitochondrial voltage-dependent anion channel 1 in tumor cells
V Shoshan-Barmatz, D Ben-Hail, L Admoni… - … et Biophysica Acta (BBA …, 2015 - Elsevier
VDAC1 is found at the crossroads of metabolic and survival pathways. VDAC1 controls
metabolic cross-talk between mitochondria and the rest of the cell by allowing the influx and …
metabolic cross-talk between mitochondria and the rest of the cell by allowing the influx and …
Voltage-dependent anion channel 1 as an emerging drug target for novel anti-cancer therapeutics
V Shoshan-Barmatz, Y Krelin… - Frontiers in …, 2017 - frontiersin.org
Cancer cells share several properties, high proliferation potential, reprogramed metabolism,
and resistance to apoptotic cues. Acquiring these hallmarks involves changes in key …
and resistance to apoptotic cues. Acquiring these hallmarks involves changes in key …
[HTML][HTML] Enolase 1 stimulates glycolysis to promote chemoresistance in gastric cancer
X Qian, W Xu, J Xu, Q Shi, J Li, Y Weng, Z Jiang… - Oncotarget, 2017 - ncbi.nlm.nih.gov
Chemotherapy is the major choice for the cancer treatment of early and advanced stages.
However, intrinsic or acquired drug resistance significantly restricts the clinical efficacy of …
However, intrinsic or acquired drug resistance significantly restricts the clinical efficacy of …
Tissue‐based proteomics reveals FXYD3, S100A11 and GSTM3 as novel markers for regional lymph node metastasis in colon cancer
S Meding, B Balluff, M Elsner, C Schöne… - The Journal of …, 2012 - Wiley Online Library
Regional lymph node metastasis negatively affects prognosis in colon cancer patients. The
molecular processes leading to regional lymph node metastasis are only partially …
molecular processes leading to regional lymph node metastasis are only partially …
A targeted proteomics approach reveals a serum protein signature as diagnostic biomarker for resectable gastric cancer
Q Shen, K Polom, C Williams, FMS de Oliveira… - …, 2019 - thelancet.com
Background Gastric cancer (GC) is the third leading cause of cancer death. Early detection
is a key factor to reduce its mortality. Methods We retrospectively collected pre-and …
is a key factor to reduce its mortality. Methods We retrospectively collected pre-and …
Discovery of biomarkers for gastric cancer: a proteomics approach
Gastric cancer is the second leading cause of cancer-related deaths worldwide. Although
many treatment options exist for patients with gastric tumors, the incidence and mortality rate …
many treatment options exist for patients with gastric tumors, the incidence and mortality rate …
Anterior gradient proteins in gastrointestinal cancers: from cell biology to pathophysiology
Most of the organs of the digestive tract comprise secretory epithelia that require specialized
molecular machines to achieve their functions. As such anterior gradient (AGR) proteins …
molecular machines to achieve their functions. As such anterior gradient (AGR) proteins …
Inducing apoptosis in chemotherapy‐resistant B‐lineage acute lymphoblastic leukaemia cells by targeting HSPA5, a master regulator of the anti‐apoptotic unfolded …
We present previously unknown evidence that the immunoglobulin heavy chain binding
protein BIP/HSPA5, also known as glucose regulated protein (GRP) 78, serving as a pivotal …
protein BIP/HSPA5, also known as glucose regulated protein (GRP) 78, serving as a pivotal …
[HTML][HTML] FBXW7 negatively regulates ENO1 expression and function in colorectal cancer
P Zhan, Y Wang, S Zhao, C Liu, Y Wang, M Wen… - Laboratory …, 2015 - Elsevier
Abstract FBXW7 (F-box and WD40 domain protein 7) is a tumor suppressor frequently
inactivated in human cancers. The precise molecular mechanisms by which FBXW7 exerts …
inactivated in human cancers. The precise molecular mechanisms by which FBXW7 exerts …
Bioinformatics analysis and experimental validation of tumorigenic role of PPIA in gastric cancer
J Liu, Y Wang, Z Zhao, Y Ge - Scientific Reports, 2023 - nature.com
Gastric cancer (GC) is a malignant tumor with high incidence rate and mortality. Due to the
lack of effective diagnostic indicators, most patients are diagnosed in late stage and have a …
lack of effective diagnostic indicators, most patients are diagnosed in late stage and have a …